Page last updated: 2024-12-09

1,4,7-trimethyl-1,4,7-triazacyclononane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1,4,7-trimethyl-1,4,7-triazacyclononane, often abbreviated as **[9]aneN3**, is a **macrocyclic polyamine** with three nitrogen atoms and three methyl groups attached to the ring.

Here's why it's important for research:

**1. Metal Complexation:** [9]aneN3 is known for its strong ability to bind metal ions, specifically transition metals. This property makes it a versatile ligand in coordination chemistry and catalysis.

**a. Coordination Chemistry:** [9]aneN3 forms stable complexes with metals like Cu(II), Ni(II), Co(II), and Zn(II). The metal complexes have defined geometries and predictable reactivity, making them useful in studying the structure and bonding of coordination compounds.

**b. Catalysis:** [9]aneN3 can act as a ligand in catalysts, facilitating various chemical reactions. The metal complexes can act as Lewis acids, oxidants, or reductants, promoting specific chemical transformations.

**2. Bioinorganic Chemistry:** [9]aneN3 has applications in understanding the role of metal ions in biological systems.

**a. Mimicking Active Sites:** The ability of [9]aneN3 to bind metals can be used to mimic the active sites of metalloenzymes, allowing researchers to study their catalytic mechanisms.

**b. Bioimaging:** [9]aneN3 can be used as a chelator for radioactive metals, creating radiopharmaceuticals for diagnostic imaging and cancer therapy.

**3. Supramolecular Chemistry:** [9]aneN3 can self-assemble into complex structures, forming supramolecular architectures with interesting properties.

**a. Host-Guest Chemistry:** [9]aneN3 can act as a host molecule, encapsulating guest molecules within its cavity. This property has potential in areas like molecular recognition and drug delivery.

**b. Nanomaterials:** [9]aneN3 can be incorporated into nanomaterials, leading to new materials with unique properties, such as controlled drug release or enhanced conductivity.

**Overall, 1,4,7-trimethyl-1,4,7-triazacyclononane ([9]aneN3) is a versatile molecule with broad applications in various research fields. Its strong metal binding properties, potential for catalysis, and ability to form complex structures make it a valuable tool for advancing our understanding of coordination chemistry, bioinorganic chemistry, and supramolecular chemistry.**

Cross-References

ID SourceID
PubMed CID546957
SCHEMBL ID151183
MeSH IDM0483557

Synonyms (29)

Synonym
1,4,7-trimethyl-1,4,7-triazonane
inchi=1/c9h21n3/c1-10-4-6-11(2)8-9-12(3)7-5-10/h4-9h2,1-3h
1,4,7-trimethyl-1,4,7-triazacyclononane, 97%
96556-05-7
octahydro-1,4,7-trimethyl-1h-1,4,7-triazonine
T1879
1,4,7-trimethyl-1,4,7-triazacyclononane
AKOS005255118
FT-0642327
SCHEMBL151183
1,4,7-trimethyl-1,4,7-triazonane #
1,4,7-trimethyl-1,4,7-triazacyclononane (stabilized with nahco3)
1h-1,4,7-triazonine, octahydro-1,4,7-trimethyl-
tmtan
mfcd00012359
DTXSID80338151
H11377
1,4,7-trimethyl-1,4,7-triazacyclononane(stabilized with nahco3)
STL554415
DS-18409
1,4,7-trimethyl-1,4,7-triazacyclononane, (stabilized with nahco3)
CS-0043769
BBL100621
tmtacn
5-isoxazolamine,3-ethyl-
unii-r7bzk76rtp
r7bzk76rtp ,
n,n',n''-trimethyl-1,4,7-triazacyclononane
HY-W051391
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (53.85)29.6817
2010's6 (46.15)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.31 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]